Evidence map›Paper›PMID 33150736›Full record

ArticleJournal of cellular and molecular medicine2020

Aldosterone enhances high phosphate-induced vascular calcification through inhibition of AMPK-mediated autophagy.

Jing-Wei Gao, Wan-Bing He, Chang-Ming Xie, Ming Gao, Lei-Yu Feng, Zhao-Yu Liu, Jing-Feng Wang, Hui Huang, Pin-Ming Liu

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Mineralocorticoid Receptor Antagonists in Dialysis.American journal of nephrology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Roles of Nuclear Receptors in Vascular Calcification.International journal of molecular sciences · 2021
    Review
  15. Article
  16. AMPK: Potential Therapeutic Target for Vascular Calcification.Frontiers in cardiovascular medicine · 2021
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jing-Wei GaoDepartment of Cardiology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China.
Wan-Bing HeDepartment of Cardiology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China.
Chang-Ming XieCardiovascular Department, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
Ming GaoDepartment of Radiology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China.
Lei-Yu FengDepartment of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhao-Yu LiuMedical Research Center, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China.
Jing-Feng WangDepartment of Cardiology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China.
Hui HuangCardiovascular Department, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.ORCID 0000-0001-8599-7441
Pin-Ming LiuDepartment of Cardiology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China.ORCID 0000-0002-4142-6863
Sun Yat-sen University · CNFirst Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It remains unclear whether the necessity of calcified mellitus induced by high inorganic phosphate (Pi) is required and the roles of autophagy plays in aldosterone (Aldo)-enhanced vascular calcification (VC) and vascular smooth muscle cell (VSMC) osteogenic differentiation. In the present study, we found that Aldo enhanced VC both in vivo and in vitro only in the presence of high Pi, alongside with increased expression of VSMC osteogenic proteins (BMP2, Runx2 and OCN) and decreased expression of VSMC contractile proteins (α-SMA, SM22α and smoothelin). However, these effects were blocked by mineralocorticoid receptor inhibitor, spironolactone. In addition, the stimulatory effects of Aldo on VSMC calcification were further accelerated by the autophagy inhibitor, 3-MA, and were counteracted by the autophagy inducer, rapamycin. Moreover, inhibiting adenosine monophosphate-activated protein kinase (AMPK) by Compound C attenuated Aldo/MR-enhanced VC. These results suggested that Aldo facilitates high Pi-induced VSMC osteogenic phenotypic switch and calcification through MR-mediated signalling pathways that involve AMPK-dependent autophagy, which provided new insights into Aldo excess-associated VC in various settings.

Indexed as

AutophagyAldosteroneAMP-Activated Protein KinasesAnimalsBiomarkersCalciumCell DifferentiationCells, CulturedFemaleGene ExpressionGenes, ReporterMiceModels, BiologicalOsteogenesisPhosphatesSignal TransductionAldosteroneAMP-Activated Protein KinasesBiomarkersCalciumPhosphatesaldosteroneautophagyphenotypic switchvascular calcificationvascular smooth muscle cell

Identifiers

PMID33150736
PMCPMC7754028
OpenAlexW3095490797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.